Siemens Healthineers and Novo announced a collaboration to expand clinical access to non-invasive blood tests, including the ELF test, for earlier detection of MASLD and MASH.
Read More
From clot formation to functional and antigen testing, fibrinogen measurement helps laboratories evaluate bleeding disorders, monitor critical illness, and support patient care.
Read More
Researchers at Johns Hopkins validated an AI-powered blood test that accurately detects liver cancer in diverse populations, using the DELFI platform to analyze cell-free DNA fragments.
Read More
Researchers from Charité – Universitätsmedizin Berlin report that steatotic liver disease subtypes often shift over time, with 36% of MetALD patients reclassified within six months, suggesting a need for dynamic disease monitoring.
Read More
The NASHnext assay, powered by GENFIT’s NIS4 technology, is designed to identify patients with at-risk MASH through a blood draw ordered via the Labcorp OnDemand platform.
Read More